CELEX:62022CJ0119: Judgment of the Court (Third Chamber) of 19 December 2024.#Teva BV and Teva Finland Oy v Merck Sharp & Dohme LLC, anciennement Merck Sharp & Dohme Corp.#Reference for a preliminary ruling – Medicinal products for human use – Supplementary protection certificate (SPC) – Regulation (EC) No 469/2009 – Conditions for obtaining an SPC for medicinal products – Article 3(a) – Concept of ‘product protected by a basic patent in force’ – Article 3(c) – Concept of ‘product the subject of an SPC’ – Criteria for assessment.#Case C-119/22.
Ta dokument v slovenščini ne obstaja.